Verition Fund Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Sell |
108,605
-162,829
| -60% | -$1.53M | ﹤0.01% | 1841 |
|
|
2025
Q1 | $1.93M | Buy |
271,434
+260,253
| +2,328% | +$1.85M | 0.01% | 1239 |
|
|
2024
Q4 | $130K | Sell |
11,181
-83,245
| -88% | -$971K | ﹤0.01% | 2385 |
|
|
2024
Q3 | $1.94M | Buy |
94,426
+50,763
| +116% | +$1.04M | 0.01% | 1006 |
|
|
2024
Q2 | $977K | Buy |
+43,663
| New | +$977K | 0.01% | 1166 |
|
|
2023
Q4 | – | Sell |
-13,200
| Closed | -$417K | – | 2115 |
|
|
2023
Q3 | $417K | Buy |
+13,200
| New | +$417K | ﹤0.01% | 1265 |
|
|
2022
Q2 | – | Sell |
-6,079
| Closed | -$442K | – | 2346 |
|
|
2022
Q1 | $442K | Buy |
+6,079
| New | +$442K | 0.01% | 1289 |
|